Evidence map›Paper›PMID 39898464›Full record

Trial reportClinical pharmacology and therapeutics2025

CB

Andriy A Gorbenko, Jules A A C Heuberger, Maria Juachon, Erica Klaassen, Michael Tagen, Joseph F Lawler, Daniel Schneeberger, Kenneth C Cundy, Linda E Klumpers, Geert J Groeneveld

Abstract readRandomized Controlled TrialClinical Trial, Phase II
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Clinical pharmacology and therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Recommendations for the Clinical Management and Prevention of Pediatric Cannabis Edible Ingestions.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andriy A GorbenkoCentre for Human Drug Research, Leiden, The Netherlands.ORCID 0000-0001-5917-7888
Jules A A C HeubergerCentre for Human Drug Research, Leiden, The Netherlands.ORCID 0000-0001-7202-5088
Maria JuachonCentre for Human Drug Research, Leiden, The Netherlands.ORCID 0009-0002-8064-2013
Erica KlaassenCentre for Human Drug Research, Leiden, The Netherlands.ORCID 0000-0003-0089-1846
Michael TagenVerdient Science, Denver, Colorado, USA.ORCID 0000-0002-8942-586X
Joseph F LawlerAnebulo Pharmaceuticals, Austin, Texas, USA.
Daniel SchneebergerAnebulo Pharmaceuticals, Austin, Texas, USA.
Kenneth C CundyAnebulo Pharmaceuticals, Austin, Texas, USA.
Linda E KlumpersVerdient Science, Denver, Colorado, USA.ORCID 0000-0003-3453-9744
Geert J GroeneveldCentre for Human Drug Research, Leiden, The Netherlands.ORCID 0000-0002-4655-6667

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emergency department visits due to cannabinoid-induced toxicity, including acute cannabinoid intoxication (ACI) have increased worldwide as more states have liberalized cannabis policy. ACI symptoms include anxiety, panic attacks, tachycardia, and psychosis, primarily mediated through cannabinoid type 1 receptor (CB

Indexed as

Cannabinoid Receptor AntagonistsDronabinolPyrazolesReceptor, Cannabinoid, CB1AdolescentAdultDose-Response Relationship, DrugDouble-Blind MethodFemaleHealthy VolunteersHeart RateHumansMaleMiddle AgedYoung AdultCannabinoid Receptor AntagonistsDronabinolPyrazolesReceptor, Cannabinoid, CB1

Identifiers

PMID39898464
PMCPMC11993283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.